2025-02-012026-01-312026-01-31false11137350CITY CARE LIMITED2026-10-21falseiso4217:GBPxbrli:pure111373502025-01-31111373502026-01-31111373502025-02-012026-01-31111373502024-01-31111373502025-01-31111373502024-02-012025-01-3111137350bus:SmallEntities2025-02-012026-01-3111137350bus:AuditExempt-NoAccountantsReport2025-02-012026-01-3111137350bus:AbridgedAccounts2025-02-012026-01-3111137350bus:PrivateLimitedCompanyLtd2025-02-012026-01-3111137350core:WithinOneYear2026-01-3111137350core:AfterOneYear2026-01-3111137350core:WithinOneYear2025-01-3111137350core:AfterOneYear2025-01-3111137350core:ShareCapital2026-01-3111137350core:SharePremium2026-01-3111137350core:RevaluationReserve2026-01-3111137350core:OtherReservesSubtotal2026-01-3111137350core:RetainedEarningsAccumulatedLosses2026-01-3111137350core:ShareCapital2025-01-3111137350core:SharePremium2025-01-3111137350core:RevaluationReserve2025-01-3111137350core:OtherReservesSubtotal2025-01-3111137350core:RetainedEarningsAccumulatedLosses2025-01-3111137350core:LandBuildings2026-01-3111137350core:PlantMachinery2026-01-3111137350core:Vehicles2026-01-3111137350core:FurnitureFittings2026-01-3111137350core:OfficeEquipment2026-01-3111137350core:NetGoodwill2026-01-3111137350core:IntangibleAssetsOtherThanGoodwill2026-01-3111137350core:ListedExchangeTraded2026-01-3111137350core:UnlistedNon-exchangeTraded2026-01-3111137350core:LandBuildings2025-01-3111137350core:PlantMachinery2025-01-3111137350core:Vehicles2025-01-3111137350core:FurnitureFittings2025-01-3111137350core:OfficeEquipment2025-01-3111137350core:NetGoodwill2025-01-3111137350core:IntangibleAssetsOtherThanGoodwill2025-01-3111137350core:ListedExchangeTraded2025-01-3111137350core:UnlistedNon-exchangeTraded2025-01-3111137350core:LandBuildings2025-02-012026-01-3111137350core:PlantMachinery2025-02-012026-01-3111137350core:Vehicles2025-02-012026-01-3111137350core:FurnitureFittings2025-02-012026-01-3111137350core:OfficeEquipment2025-02-012026-01-3111137350core:NetGoodwill2025-02-012026-01-3111137350core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3111137350core:ListedExchangeTraded2025-02-012026-01-3111137350core:UnlistedNon-exchangeTraded2025-02-012026-01-3111137350core:MoreThanFiveYears2025-02-012026-01-3111137350core:Non-currentFinancialInstruments2026-01-3111137350core:Non-currentFinancialInstruments2025-01-3111137350dpl:CostSales2025-02-012026-01-3111137350dpl:DistributionCosts2025-02-012026-01-3111137350core:LandBuildings2025-02-012026-01-3111137350core:PlantMachinery2025-02-012026-01-3111137350core:Vehicles2025-02-012026-01-3111137350core:FurnitureFittings2025-02-012026-01-3111137350core:OfficeEquipment2025-02-012026-01-3111137350dpl:AdministrativeExpenses2025-02-012026-01-3111137350core:NetGoodwill2025-02-012026-01-3111137350core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3111137350dpl:GroupUndertakings2025-02-012026-01-3111137350dpl:ParticipatingInterests2025-02-012026-01-3111137350dpl:GroupUndertakingscore:ListedExchangeTraded2025-02-012026-01-3111137350core:ListedExchangeTraded2025-02-012026-01-3111137350dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-02-012026-01-3111137350core:UnlistedNon-exchangeTraded2025-02-012026-01-3111137350dpl:CostSales2024-02-012025-01-3111137350dpl:DistributionCosts2024-02-012025-01-3111137350core:LandBuildings2024-02-012025-01-3111137350core:PlantMachinery2024-02-012025-01-3111137350core:Vehicles2024-02-012025-01-3111137350core:FurnitureFittings2024-02-012025-01-3111137350core:OfficeEquipment2024-02-012025-01-3111137350dpl:AdministrativeExpenses2024-02-012025-01-3111137350core:NetGoodwill2024-02-012025-01-3111137350core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3111137350dpl:GroupUndertakings2024-02-012025-01-3111137350dpl:ParticipatingInterests2024-02-012025-01-3111137350dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3111137350core:ListedExchangeTraded2024-02-012025-01-3111137350dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3111137350core:UnlistedNon-exchangeTraded2024-02-012025-01-3111137350core:NetGoodwill2026-01-3111137350core:IntangibleAssetsOtherThanGoodwill2026-01-3111137350core:LandBuildings2026-01-3111137350core:PlantMachinery2026-01-3111137350core:Vehicles2026-01-3111137350core:FurnitureFittings2026-01-3111137350core:OfficeEquipment2026-01-3111137350core:AfterOneYear2026-01-3111137350core:WithinOneYear2026-01-3111137350core:ListedExchangeTraded2026-01-3111137350core:UnlistedNon-exchangeTraded2026-01-3111137350core:ShareCapital2026-01-3111137350core:SharePremium2026-01-3111137350core:RevaluationReserve2026-01-3111137350core:OtherReservesSubtotal2026-01-3111137350core:RetainedEarningsAccumulatedLosses2026-01-3111137350core:NetGoodwill2025-01-3111137350core:IntangibleAssetsOtherThanGoodwill2025-01-3111137350core:LandBuildings2025-01-3111137350core:PlantMachinery2025-01-3111137350core:Vehicles2025-01-3111137350core:FurnitureFittings2025-01-3111137350core:OfficeEquipment2025-01-3111137350core:AfterOneYear2025-01-3111137350core:WithinOneYear2025-01-3111137350core:ListedExchangeTraded2025-01-3111137350core:UnlistedNon-exchangeTraded2025-01-3111137350core:ShareCapital2025-01-3111137350core:SharePremium2025-01-3111137350core:RevaluationReserve2025-01-3111137350core:OtherReservesSubtotal2025-01-3111137350core:RetainedEarningsAccumulatedLosses2025-01-3111137350core:NetGoodwill2024-01-3111137350core:IntangibleAssetsOtherThanGoodwill2024-01-3111137350core:LandBuildings2024-01-3111137350core:PlantMachinery2024-01-3111137350core:Vehicles2024-01-3111137350core:FurnitureFittings2024-01-3111137350core:OfficeEquipment2024-01-3111137350core:AfterOneYear2024-01-3111137350core:WithinOneYear2024-01-3111137350core:ListedExchangeTraded2024-01-3111137350core:UnlistedNon-exchangeTraded2024-01-3111137350core:ShareCapital2024-01-3111137350core:SharePremium2024-01-3111137350core:RevaluationReserve2024-01-3111137350core:OtherReservesSubtotal2024-01-3111137350core:RetainedEarningsAccumulatedLosses2024-01-3111137350core:AfterOneYear2025-02-012026-01-3111137350core:WithinOneYear2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:CostValuation2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3111137350core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3111137350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-3111137350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3111137350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-3111137350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-3111137350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-3111137350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-3111137350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-3111137350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-3111137350core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3111137350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3111137350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3111137350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3111137350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3111137350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3111137350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3111137350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3111137350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3111137350bus:Director12025-02-012026-01-31

CITY CARE LIMITED

Registered Number
11137350
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

CITY CARE LIMITED
Company Information
for the year from 1 February 2025 to 31 January 2026

Director

Mr Z Mohammed

Registered Address

Flat 15 13 Atlas Place
Manchester
M19 3XR

Registered Number

11137350 (England and Wales)
CITY CARE LIMITED
Balance Sheet as at
31 January 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets34,7664,974
4,7664,974
Current assets
Debtors4344388
Cash at bank and on hand8,0053,543
8,3493,931
Creditors amounts falling due within one year5(19,465)(16,964)
Net current assets (liabilities)(11,116)(13,033)
Total assets less current liabilities(6,350)(8,059)
Creditors amounts falling due after one year6-(3,798)
Net assets(6,350)(11,857)
Capital and reserves
Called up share capital100100
Profit and loss account(6,450)(11,957)
Shareholders' funds(6,350)(11,857)
The financial statements were approved and authorised for issue by the Director on 21 October 2026, and are signed on its behalf by:
Mr Z Mohammed
Director
Registered Company No. 11137350
CITY CARE LIMITED
Notes to the Financial Statements
for the year ended 31 January 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Fixtures and fittings-4
Vehicles20-
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

20262025
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 February 2514,400
Additions1,300
Revaluations(7,400)
At 31 January 268,300
Depreciation and impairment
At 01 February 259,426
Charge for year1,508
Revaluation surplus(7,400)
At 31 January 263,534
Net book value
At 31 January 264,766
At 31 January 254,974
4.Debtors: amounts due within one year

2026

2025

££
Other debtors344388
Total344388
5.Creditors: amounts due within one year

2026

2025

££
Bank borrowings and overdrafts18,94115,964
Taxation and social security333-
Other creditors1911,000
Total19,46516,964
6.Creditors: amounts due after one year

2026

2025

££
Bank borrowings and overdrafts-3,798
Total-3,798
7.Share capital
Allotted, Called up and fully paid 100 100